Meritage Portfolio Management Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Meritage Portfolio Management reduced its stake in UnitedHealth Group Inc by 1.11% during the most recent quarter end. The investment management company now holds a total of 40,884 shares of UnitedHealth Group Inc which is valued at $5,483,771 after selling 460 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Apr 21, 2016.UnitedHealth Group Inc makes up approximately 0.62% of Meritage Portfolio Management’s portfolio.

UnitedHealth Group Inc closed down -1.44 points or -1.07% at $132.8 with 33,58,755 shares getting traded on Wednesday. Post opening the session at $134.34, the shares hit an intraday low of $131.9 and an intraday high of $134.58 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Strs Ohio sold out all of its stake in UNH during the most recent quarter. The investment firm sold 1,228,541 shares of UNH which is valued $164,784,204. Perkins Capital Management Inc sold out all of its stake in UNH during the most recent quarter. The investment firm sold 13,350 shares of UNH which is valued $1,790,636.1st Global Advisors boosted its stake in UNH in the latest quarter, The investment management firm added 3,511 additional shares and now holds a total of 15,059 shares of UnitedHealth Group Inc which is valued at $1,917,462. UnitedHealth Group Inc makes up approx 0.27% of 1st Global Advisors’s portfolio.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.